Bionime Corporation (4737.TW) TAI

Currency In TWD

AD

Valuation

Market Cap4B
Enterprise Value6.64B
P/E Ratio-16.11
PEG Ratio0.25
Price/Sales Ratio2.52
Price/Book Ratio1.92
Enterprise/Revenue3.75
Enterprise/EBITDA-62.73

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin-0.14
Operating Margin-0.16
AD

Management Effectiveness

Return On Assets-0.04
Return On Equity-0.13

Income Statement

Revenue1.84B
Revenue/Share24.01
Gross Profit627.81M
EBITDA-15.08M
Net Income-180.28M
Diluted EPS-2.65

Balance Sheet

Total Cash449.44M
Total Cash/Share6.12
Total Debt2.56B
Total Debt/Equity1.16
Current Ratio0.85
Book Value Per Share30.15

Price History

52-Week Change-17.93
52-Week High73.9
52-Week Low49.75
Moving Average 50 Days59.26
Moving Average 200 Days60.02

Statistics

Average Volume147,241
Shares Outstanding77.29M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1099:1000
Last Split DateSeptember 08, 2025
AD